Global Gonorrhea Diagnostics Market Growth (Status and Outlook) 2023-2029

Global Gonorrhea Diagnostics Market Growth (Status and Outlook) 2023-2029

Gonorrhea is a sexually transmitted disease caused by the bacterium Neisseria gonorrhoeae and can affect both genders. It is a common infection, especially among young people aged between 15 years to 24 years. According to the U.S. Centers for Disease Control and Prevention (CDC), gonorrhea is the second most commonly reported disease in the United States affecting approximately 800,000 people each year. In the United Kingdom, about 28,000 cases of gonorrhea are reported each year. Symptoms of gonorrhea in men encompass painful urination, swelling of testicles and pus discharge. In women, symptoms comprise excessive vaginal discharge, painful urination and abdominal pain. Complications include ectopic pregnancy, Pelvic Inflammatory Disease (PID) and Epididymitis. The incubation period for this disease also varies between men and women. In men, the symptoms occur between 2 to 14 days whereas in women it takes 7 days to 21 days to show symptoms. Astonishingly, about 50% of women have no symptoms in the early stage and during pregnancy it may infect the fetus during delivery.

LPI (LP Information)' newest research report, the “Gonorrhea Diagnostics Industry Forecast” looks at past sales and reviews total world Gonorrhea Diagnostics sales in 2022, providing a comprehensive analysis by region and market sector of projected Gonorrhea Diagnostics sales for 2023 through 2029. With Gonorrhea Diagnostics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Gonorrhea Diagnostics industry.

This Insight Report provides a comprehensive analysis of the global Gonorrhea Diagnostics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Gonorrhea Diagnostics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Gonorrhea Diagnostics market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Gonorrhea Diagnostics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Gonorrhea Diagnostics.

The global Gonorrhea Diagnostics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

There has been a recent rise in the incidences of gonorrhea across the globe due to the adoption of risky sexual behavior and unsafe sexual practices. According to the CDC, gonorrhea is the second most commonly reported communicable disease after chlamydia. The highest occurrence rates of gonorrhea are primarily in heterosexually infected men, especially those aged 25-34 years. These increasing incidences of gonorrhea will enhance the demand for gonorrhea diagnostic products during the forecast period.

This report presents a comprehensive overview, market shares, and growth opportunities of Gonorrhea Diagnostics market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type
Chromatography
Diagnostic Imaging
Differential Light Scattering
Flow Cytometry
Gel Microdroplets
Immunoassay
Molecular Diagnostics
Monoclonal Antibodies Test

Segmentation by application
Hospitals
Ambulatory Surgical Centers
Diagnostic Centers
Clinics
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Abbott Laboratories
Beckman Coulter
Roche Diagnostics
Siemens
bioMérieux
PerkinElmer
Ortho Clinical Diagnostics

Please note: The report will take approximately 2 business days to prepare and deliver.